Gene delivery to cartilage defects using coagulated bone marrow aspirate

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Gene Therapy

Background:

• Osteochondral defects present significant challenges for natural cartilage repair.
• Current gene delivery methods for cartilage repair face limitations, including vector leakage.
• Targeting bone marrow-derived cells offers a potential strategy for in situ genetic modification.

Purpose of the Study:

• To evaluate bone marrow-derived cells for gene delivery to cartilage lesions.
• To investigate coagulated bone marrow aspirates as an alternative gene delivery vehicle.
• To assess the efficacy and containment of gene delivery using bone marrow clots in osteochondral defects.

Main Methods:

• Surgically created osteochondral defects in rabbit femoral condyles.
• Implantation of collagen-glycosaminoglycan (CG) matrices preloaded with adenoviral vectors.
• Investigation of coagulated bone marrow aspirates mixed with adenoviral suspension.
• In vitro and in vivo assessment of transgenic gene expression and vector containment.

Main Results:

• Transgenic expression was observed up to 21 days with CG matrices, but significant vector/cell leakage occurred.
• Bone marrow clots showed uniform adenoviral vector dispersion and expression proportional to cell density.
• Vector-seeded and cell-seeded bone marrow clots maintained structural integrity and transgenic expression for weeks.
• In vivo, bone marrow clots provided high transgenic expression in defects with improved vector containment compared to CG matrices.

Conclusions:

• Coagulated bone marrow aspirates are a feasible and effective medium for gene delivery to cartilage.
• Bone marrow clots offer a natural, host-derived matrix for gene delivery and tissue repair.
• This approach shows promise for enhancing repair in cartilage and other musculoskeletal tissues.